196 related articles for article (PubMed ID: 3815345)
1. Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells.
Bardon S; Vignon F; Montcourrier P; Rochefort H
Cancer Res; 1987 Mar; 47(5):1441-8. PubMed ID: 3815345
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
3. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
Horwitz KB
Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer.
Schoenlein PV; Hou M; Samaddar JS; Gaddy VT; Thangaraju M; Lewis J; Johnson M; Ganapathy V; Kallab A; Barrett JT
Int J Oncol; 2007 Sep; 31(3):643-55. PubMed ID: 17671693
[TBL] [Abstract][Full Text] [Related]
5. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
[TBL] [Abstract][Full Text] [Related]
6. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
7. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen.
Taylor CM; Blanchard B; Zava DT
Cancer Res; 1984 Apr; 44(4):1409-14. PubMed ID: 6704959
[TBL] [Abstract][Full Text] [Related]
10. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
12. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
15. [Antiestrogens and normal human breast cell proliferation].
Mauvais-Jarvis P; Gompel A; Malet C; Kuttenn F
Ann Endocrinol (Paris); 1989; 50(3):181-8. PubMed ID: 2683973
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of antihormone action.
Gronemeyer H; Benhamou B; Berry M; Bocquel MT; Gofflo D; Garcia T; Lerouge T; Metzger D; Meyer ME; Tora L
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):217-21. PubMed ID: 1562505
[TBL] [Abstract][Full Text] [Related]
17. Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?
Rosenberg Zand RS; Grass L; Magklara A; Jenkins DJ; Diamandis EP
Breast Cancer Res Treat; 2000 Mar; 60(1):1-8. PubMed ID: 10845803
[TBL] [Abstract][Full Text] [Related]
18. The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription.
Nawaz Z; Stancel GM; Hyder SM
Cancer Res; 1999 Jan; 59(2):372-6. PubMed ID: 9927049
[TBL] [Abstract][Full Text] [Related]
19. Effects of antiestrogen versus antiprogestin on transformed and nontransformed steroid receptors.
Turner JW; Ruh MF; Ward DT; Ruh TS
J Steroid Biochem Mol Biol; 1991 Feb; 38(2):197-203. PubMed ID: 2004041
[TBL] [Abstract][Full Text] [Related]
20. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
